Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
45.71 USD | +0.44% |
|
+1.67% | -14.72% |
07/05 | DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating | MT |
01/05 | Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.72% | 87Cr | |
+13.80% | 809.34Cr | |
+0.47% | 738.52Cr | |
-8.08% | 537.02Cr | |
-7.37% | 362.86Cr | |
-19.73% | 327.25Cr | |
-12.00% | 119.12Cr | |
-26.41% | 113.46Cr | |
+0.89% | 88Cr | |
-12.86% | 85Cr |
- Stock Market
- Equities
- USNA Stock
- News USANA Health Sciences, Inc.
- DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating